Literature DB >> 20174893

Anti-cytokeratin CAM 5.2 is specific for K8 and to a lesser extent for the closely related K7, but shows no reactivity with K18 or K19: comment on: "keratin expression in endocrine organs and their neoplasms" Endocr Pathol. 2009 Spring; 20(1):1-10.

Pin-Jie Chen, Jeng-Dong Hsu, Chih-Ping Han.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20174893     DOI: 10.1007/s12022-010-9108-9

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


× No keyword cloud information.
  3 in total

1.  Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia.

Authors:  F Smedts; F Ramaekers; H Robben; M Pruszczynski; G van Muijen; B Lane; I Leigh; P Vooijs
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

2.  True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.

Authors:  Jeng-Dong Hsu; Chung-Chin Yao; Ming-Yung Lee; Lai-Fong Kok; Po-Hui Wang; Yeu-Sheng Tyan; Chin-Ping Han
Journal:  Int J Gynecol Pathol       Date:  2010-05       Impact factor: 2.762

Review 3.  Keratin expression in endocrine organs and their neoplasms.

Authors:  Peiguo G Chu; Sean K Lau; Lawrence M Weiss
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

  3 in total
  2 in total

1.  High expression of cytokeratin CAM5.2 in esophageal squamous cell carcinoma is associated with poor prognosis.

Authors:  Shujin He; Jie Peng; Lei Li; Ying Xu; Xiaoxiao Wu; Juan Yu; Jianli Liu; Jinguo Zhang; Renya Zhang; Wei Wang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

2.  Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma.

Authors:  Yuanxiang Lu; Dongxiao Li; Ge Liu; Erwei Xiao; Senmao Mu; Yujin Pan; Fangyuan Qin; Yaping Zhai; Shaofeng Duan; Deyu Li; Guoyi Yan
Journal:  Onco Targets Ther       Date:  2021-01-27       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.